Skip to content
OpenCapital
Get started

Catalyst Pharmaceutical CPRX Invested capital

Discontinued — last reported Q1 '26

Invested capital at other companies

Griffon logo
GriffonGFF
5.9%-9.9pp
Benchmark Electronics logo
Benchmark ElectronicsBHE
3.8%-1.7pp
Power Integrations logo
Power IntegrationsPOWI
1.5%-1.0pp
Hayward Holdings logo
Hayward HoldingsHAYW
8.3%+0.8pp
Chemours logo
ChemoursCC
-0.6%-4.1pp
United States Lime & Minerals, Inc. logo
United States Lime & Minerals, Inc.USLM
46.5%-2.9pp

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K—
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0×0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

$2.7Mtotal debt+$1.0Btotal stockholders equity−$755.9Mcash and equivalents=$259.52M

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's invested capital.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's invested capital?
Catalyst Pharmaceutical (CPRX) reported invested capital of $259.52M in Q1 2026.
How has Catalyst Pharmaceutical's invested capital changed year-over-year?
Catalyst Pharmaceutical's invested capital increased by 19.7% year-over-year, from $216.72M to $259.52M.
What is the long-term trend for Catalyst Pharmaceutical's invested capital?
Over 5 years (2020 to 2025), Catalyst Pharmaceutical's invested capital has grown at a 44.5% compound annual growth rate (CAGR), from $39.39M to $247.88M.
What does invested capital mean?
Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).